ZA904151B - Method of treating catabolic,gut-associated pathological processes and impaired host defenses - Google Patents

Method of treating catabolic,gut-associated pathological processes and impaired host defenses

Info

Publication number
ZA904151B
ZA904151B ZA904151A ZA904151A ZA904151B ZA 904151 B ZA904151 B ZA 904151B ZA 904151 A ZA904151 A ZA 904151A ZA 904151 A ZA904151 A ZA 904151A ZA 904151 B ZA904151 B ZA 904151B
Authority
ZA
South Africa
Prior art keywords
gut
pathological processes
associated pathological
host defenses
catabolic
Prior art date
Application number
ZA904151A
Other languages
English (en)
Inventor
Robert J Smith
J Smith Robert
Douglas W Wilmore
W Wilmore Douglas
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23419606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA904151(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Publication of ZA904151B publication Critical patent/ZA904151B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Seasonings (AREA)
  • Looms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Packaging Of Machine Parts And Wound Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA904151A 1989-06-02 1990-05-30 Method of treating catabolic,gut-associated pathological processes and impaired host defenses ZA904151B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36083989A 1989-06-02 1989-06-02

Publications (1)

Publication Number Publication Date
ZA904151B true ZA904151B (en) 1991-03-27

Family

ID=23419606

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904151A ZA904151B (en) 1989-06-02 1990-05-30 Method of treating catabolic,gut-associated pathological processes and impaired host defenses

Country Status (16)

Country Link
EP (1) EP0401056B2 (xx)
JP (4) JP3068644B2 (xx)
KR (1) KR0178799B1 (xx)
AT (1) ATE160089T1 (xx)
AU (1) AU641403B2 (xx)
DE (1) DE69031694T3 (xx)
DK (1) DK0401056T4 (xx)
ES (1) ES2111529T5 (xx)
FI (1) FI915677A0 (xx)
GR (1) GR3025678T3 (xx)
HU (1) HU220214B (xx)
IL (1) IL94549A (xx)
NO (1) NO914730D0 (xx)
PT (1) PT94223B (xx)
WO (1) WO1990014823A1 (xx)
ZA (1) ZA904151B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JPH0569836U (ja) * 1992-02-25 1993-09-21 松下電工株式会社 ピアノハンドル式スイッチ
US5438075A (en) 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
DE69530570T2 (de) * 1994-01-11 2004-03-18 Stichting, Zofia Verfahren zur behandlung von stoehrungen des menschlichen oder tierischen koerpers durch verabreichung von aminosaeuren
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
BRPI0415480B1 (pt) * 2003-10-16 2019-09-17 Nestec S.A. Composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia
US8633192B2 (en) 2006-12-15 2014-01-21 Tima Foundation Compositions and uses thereof
EA016926B1 (ru) * 2006-12-15 2012-08-30 Тима Фаундейшн Композиции для профилактики и лечения гипергликемии
EP2612560A1 (en) 2012-01-09 2013-07-10 N.V. Nutricia Glutamine enriched nutritional composition for preterm infants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction

Also Published As

Publication number Publication date
IL94549A (en) 1996-08-04
DK0401056T4 (da) 2007-07-16
DK0401056T3 (da) 1998-07-27
PT94223B (pt) 1997-04-30
PT94223A (pt) 1991-02-08
FI915677A0 (fi) 1991-12-02
EP0401056A3 (en) 1991-09-25
KR0178799B1 (ko) 1999-03-20
AU5827190A (en) 1991-01-07
DE69031694T2 (de) 1998-03-12
JP3113876B2 (ja) 2000-12-04
JP2000186035A (ja) 2000-07-04
GR3025678T3 (en) 1998-03-31
HU220214B (hu) 2001-11-28
HUT61193A (en) 1992-12-28
JP3113877B2 (ja) 2000-12-04
EP0401056A2 (en) 1990-12-05
NO914730D0 (no) 1991-12-02
EP0401056B2 (en) 2007-06-13
ES2111529T5 (es) 2007-11-16
ATE160089T1 (de) 1997-11-15
EP0401056B1 (en) 1997-11-12
ES2111529T3 (es) 1998-03-16
KR920700629A (ko) 1992-08-10
JPH05500655A (ja) 1993-02-12
DE69031694D1 (de) 1997-12-18
AU641403B2 (en) 1993-09-23
JP3068644B2 (ja) 2000-07-24
IL94549A0 (en) 1991-03-10
JP2000186034A (ja) 2000-07-04
JP2000198733A (ja) 2000-07-18
WO1990014823A1 (en) 1990-12-13
DE69031694T3 (de) 2007-10-18
JP3113878B2 (ja) 2000-12-04

Similar Documents

Publication Publication Date Title
DK0862865T3 (da) Behandling af tobak
ZA904151B (en) Method of treating catabolic,gut-associated pathological processes and impaired host defenses
HU9402157D0 (en) Parathyroid hormon and raloxifene for increasing bone mass
EP0434333A3 (en) Tobacco extract treatment process
DE69225993T2 (de) Verfahren zur Behandlung von Erz mit rückgewinnbaren Metallwertstoffen einschliesslich arsenhaltiger Komponenten
GB8901759D0 (en) Method of and apparatus for sorting and/or confirming the identity of gems
IT1133069B (it) Procedimento e dispositivo per l estrazione e trattamento di materie solide da soluzioni o sospensioni particolarmente da acque di macellazione a scopo di ricupero
CS162291A3 (en) Process for treating residues obtained from leaching barium sulfide or strontium sulfide
EP0423777A3 (en) Method of treating gastrointestinal motility disorders
EP0608212A4 (en) PROCESS FOR TREATING VIRAL INFECTIONS.
GB2082100B (en) Method and apparatus for bruting precious or semi-precious stones
DE69014057D1 (de) Verfahren zur Schmelzreduktion von Metallen und Schmelzreduktionsofen.
CA2057055A1 (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
DE59002951D1 (de) Verfahren und vorrichtung zur vakuumbehandlung von metallen.
WO1998006431A3 (en) Method for treating diabetes
CA2214036A1 (en) Tobacco treatment
ZA907103B (en) Recovery of volatile metals from fume condensate
ATE102633T1 (de) Chelatbildende harze und verfahren zur verwendung zum extrahieren von metallionen.
HU9301743D0 (en) Method for extracting alginites from mines and its processing
PL269183A1 (en) Electroslag remelting method
YU78489A (en) Process for removing sulphur from smoke gasses by using ammonia